Pengobatan Suportif Vitamin D Mempercepat Konversi Sputum dan Perbaikan Gambaran Radiologis Penderita T uberkulosis

Authors

  • Siswanto Siswanto Laboratorium Ilmu Kesehatan Masyarakat Fakultas Kedokteran Universitas Brawijaya Malang
  • Sumarno Sumarno Laboratorium Mikrobiologi Fakultas Kedokteran Universitas Brawijaya
  • Yani Jane Laboratorium Ilmu Penyakit Paru Fakultas Kedokteran Universitas Brawijaya /RSSA Malang
  • Oeryana Agustin Widayanti Laboratorium Ilmu Penyakit Paru Fakultas Kedokteran Universitas Brawijaya /RSSA Malang
  • Nunuk Sri Muktiati Laboratorium Ilmu Penyakit Paru Fakultas Kedokteran Universitas Brawijaya /RSSA Malang

DOI:

https://doi.org/10.21776/ub.jkb.2009.025.03.6

Abstract

Pulmonary T uberculosis remains  as a major health problem in  South East Asia as well as Indonesia.  The failure  of  tuberculosis  treatment  is  mostly  due  to  drop-out  and  multiple  drugs  resistant.  Previous  study  showed that  Vitamin  D  increase  the  intracellular  cathelicidin  which  has  potency  to  kill  the  Mycobacterium tuberculosis. This research was aimed to identify the effect of Vitamin D as supportive treatment  on the improvement of sputum  conversion,  radiographic  finding  and  TNF-α  serum  concentration.  A  Double-blind randomized  control trial  was  used  in  two  random  allocated  patient  group  with  standard  tuberculosis  treatment.   The  first  group  was treated  with Vitamin  D (800  iu/day)  while the  other was not. Subjects were evaluated using three  parameters i.e.  sputum  conversion,  radiographic  finding  and  TNF-α  serum  concentration.  Compared to  the  group  without vitamin  D  supplementation,  group  with  vitamin  D  has  higher  proportion  of  sputum  conversion  in  the  first  month (67%    vs. 34%, p=0,04) and second month (95%  vs. 77%, p=0,18).    Improvement  in  radiographic  findings  in the  group with vitamin D is  also higher in  the  first  month (67%  vs. 18%, p=0,02) and second month (76%    vs. 45%,  p=0,06).    There is  a  significant  difference  in  the  level  of  25-dihidroxyvitamin  D between  two  groups (p=0,00). However,  there  is  no significant difference in  the  level  of TNF-α between two  groups (p=0,76) after two  months.

Downloads

Download data is not yet available.

References

Perhimpunan Dokter Paru Indonesia (PDPI). Tuberkulosis : Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Indah Offset Citra Grafika, Jakarta; 2006;5 40.

Pardosi JF. Tuberkulosis di Indonesia 2007. Online [WWW]. 2007. Http://www.litbang.depkes.go.id. [diakses 12 Desember 2007].

Anonymous. Lembar Fakta Tuberkulosis. Online [WWW].2007.http://tbcindonesia.or.id/TB_Fachsheet_Indonesia rev NTP_final_220307.pdf. [diakses 12 Desember 2007].

Siswanto, Setijowati N, Zuhriyah L, Abijoso. Pengembangan Model Pelayanan Pengobatan Tuberkulosis untuk Menurunkan Angka Putus Berobat Penderita Tuberkulosis di RSUD dr. Saiful Anwar Malang: Studi Eksperimental. Jurnal Epidemiologi Indonesia.2005;7(I):7 12.

WHO regional office for South-East Asia. TB in South-East Asia.2007

Liu PT, Stenger S, Li H et al. Toll Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response.Sciencexpress.2006;24:1770-1773.

Tomansinsig L, Zanetti M. The cathelicidins Structure, Function and Evolution. Current Protein and Peptide Science. Italy. 2005;6:23 34.

Rigby WF, Denome S & Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.J Clin Invest.1987;79:1659-1664.

Adams J, Liu P, Geffen D. Vitamin D in Defense of The Human Immune Response. Annals of the New York Academy of Science. Skeletal Biology and Medicine. New York.2007(I);1-18.

Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan Besar Sampel dalam Dasar-dasar Metodologi Penelitian Klinis. Bagian Ilmu Kesehatan Anak Fakultas Kedokteran Universitas Indonesia. PT Binarupa Aksara. Jakarta.1995;187-212.

Soegondo S. Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus tipe 2 di Indonesia.PERKENI.2006.

Holick MF. Vitamin D Deficiency. N England J Medicine. Boston.2007;357;266 81.

Gibney KB, MacGregor L, Leder K et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis.2008;46:443-446.

Rajakumar K, Greenspan SL, Thomas SB, Holick MF. Solar ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health.2007;97;1746-1754.

Palomino J.C, Leao S.C, Ritacco. Tuberculosis from basic science to patient care. Online [WWW]. 2007. Http://www.Tuberculosis Textbook.com. [diakses 10 Januari 2008].

Hsieh SM, Hung CC, Chen MY, Sheng WH, and Chang SC. Dynamics of plasma cytokine levels in patient with advanced HIV infection and active tuberculosis: implications for early recognition of patient with poor response to anti-tuberculosis treatment. AIDS.1999;13;935-941.

Xiao-ping Q, Pei L, Gang L et al. 1,25-dihydroxyvitamin D regulates LPS-induced cytokine production and reduces mortality in rats. World Journal of Gastroenrerology.2008;14(24);3897-3902.

Hakim I & Bar-Shavit Z. Modulation of TNF-a expression in bone marrow macrophages: involvement of vitamin D response element. J Cell Biochem.2003;88:986998.

Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV & Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses Growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998;66:53145321 nd

Rom WN and Garay SM. Tuberculosis. 2 edition. Lippincot Williams and Wilkins, Philadelphia. 2004;251 379.

Nursyam E.W., Z. Amin & C.M. Rumende. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indonesia. 2006;38:3-5.

Alsagaff H, Mukty HA. Tuberkulosis paru dalam Dasar-dasar Ilmu Penyakit Paru. Airlangga University Press. Cetakan kedua. Surabaya.2002;73 109.

Downloads

Published

2013-04-21

Issue

Vol. 25 No. 3 (2009)

Section

Research Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Most read articles by the same author(s)

1 2 > >>